TrialBMC medicine2023

Safety, pharmacokinetics, and pharmacodynamics of SHR7280, an oral gonadotropin-releasing hormone receptor antagonist, in healthy men: a randomized, double-blind, placebo-controlled phase 1 study.

Xin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.